Liquid Biopsy Market Dynamics | Innovations Transforming Cancer…

A liquid biopsy is an innovative and minimally invasive alternative to traditional surgical biopsies, allowing for the detection of tumors through a small blood sample. This method can be instrumental in identifying the most effective treatment for patients by analyzing DNA traces of cancer in their bloodstream. Liquid biopsies are particularly valuable in the diagnosis and screening of non-small cell lung cancer (NSCLC) and serve as companion diagnostics for various other cancers, including gastrointestinal, colorectal, breast, prostate, and ovarian cancers.